Suchergebnisse - (Person:"Fakhouri, Fadi")

PubPharm (15)

1

Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2022

von Lomax-Browne, H. | Medjeral-Thomas, N. | Barbour, S. | +22

CommentIn: Clin J Am Soc Nephrol. 2022 Jul;17(7):945-948. - PMID 35777835

2

The Rational Use of Complement Inhibitors in Kidney Diseases

enthalten in: Kidney international reports | 2022

von Fakhouri, F. | Schwotzer, N. | Golshayan, D. | +1

3

Practical management of C3 glomerulopathy and Ig-mediated MPGN : facts and uncertainties

enthalten in: Kidney international | 2020

von Fakhouri, F. | Le Quintrec, M. | Frémeaux-Bacchi, V.

4

Monitoring Complement Activation : The New Conundrum in Thrombotic Microangiopathies

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2019

von Fakhouri, F. | Frémeaux-Bacchi, V.

CommentOn: Clin J Am Soc Nephrol. 2019 Dec 6;14(12):1719-1732. - PMID 31694864

5

Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome

enthalten in: Journal of the American Society of Nephrology : JASN | 2019

von Zuber, J. | Frimat, M. | Caillard, S. | +42

6

Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors

enthalten in: Kidney international | 2019

von Le Clech, A. | Simon-Tillaux, N. | Provôt, F. | +13

CommentIn: Kidney Int. 2019 Jun;95(6):1298-1300. - PMID 31122707

7

Eculizumab prevents thrombotic microangiopathy in patients with atypical haemolytic uraemic syndrome in a long-term observational study

enthalten in: Clinical kidney journal | 2019

von Menne, J. | Delmas, Y. | Fakhouri, F. | +10

8

Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome

enthalten in: Kidney international | 2018

von Schaefer, F. | Ardissino, G. | Ariceta, G. | +29

9

Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy

enthalten in: American journal of kidney diseases : the official journal of the National Kidney Foundation | 2018

von Le Quintrec, M. | Lapeyraque, A. | Lionet, A. | +14

CommentIn: Am J Kidney Dis. 2018 Dec;72(6):906-907. - PMID 30236629

10

C5 nephritic factors drive the biological phenotype of C3 glomerulopathies

enthalten in: Kidney international | 2017

von Marinozzi, M. | Chauvet, S. | Le Quintrec, M. | +13

CommentIn: Nat Rev Nephrol. 2017 Oct;13(10):597. - PMID 28757638